Drug Profile
Aripiprazole oral soluble film - CMG Pharmaceutical
Alternative Names: Aripiprazole - CMG PharmaceuticalLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator CMG Pharmaceutical
- Class Antidepressants; Antipsychotics; Behavioural disorder therapies; Chlorobenzenes; Mood stabilisers; Piperazines; Quinolines; Small molecules
- Mechanism of Action 5-HT1A serotonin receptor agonists; Dopamine D2 receptor agonists; Dopamine D3 receptor antagonists; Dopamine D4 receptor antagonists; Serotonin 2A receptor antagonists; Serotonin 2C receptor agonists; Serotonin 7 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 28 Nov 2018 No recent reports of development identified for phase-I development in Schizophrenia in Canada (PO, Film)
- 28 Nov 2018 No recent reports of development identified for phase-I development in Schizophrenia in USA (PO, Film)
- 01 Mar 2016 CMG Pharmaceutical completes a phase I trial in Schizophrenia in Canada, USA (PO) (NCT02501109)